Why BlackRock, Nvidia, and Temasek are betting billions on quantum computing

VC investment in quantum computing hit a record $3.9 billion across 125 deals in 2025, with Q1 2026 already at $1.2 billion and Q3 2025 alone reaching $1.6 billion. The capital base has broadened sharply, led by BlackRock ($1.7 billion) and Nvidia ($1.6 billion), while venture growth’s share of deal value rose to 30.4% from about 1% in 2024. The article also highlights major exits and listings, including Quantinuum’s $1.68 billion Nasdaq IPO and $5.7 billion in Q1 2026 exits across four deals, but notes commercialization remains years away.

Analysis

The capital formation shift matters more than the headline funding totals: quantum is being re-rated from a science-project market into a strategic compute stack adjacent to AI infrastructure. That changes the marginal buyer from prestige-seeking specialists to balance-sheet allocators who can underwrite long-dated technical risk, which should compress financing risk for the few platform leaders while widening the moat against subscale competitors. In practice, this likely creates a barbell: a handful of well-capitalized winners attract nearly all follow-on capital, while the long tail of startups gets stranded, increasing M&A probability and reducing the value of independent “pick-and-shovel” vendors.

For NVDA, the market is likely to extrapolate quantum as an option on future accelerator demand, but the nearer-term benefit is softer: strategic control over the ecosystem and tighter coupling of quantum workflows with AI/HPC stacks. The second-order effect is that any credible hybrid quantum-AI architecture reinforces GPU relevance rather than displacing it, because quantum will need classical orchestration, error correction, and simulation layers for years. That makes the real competitive risk not “quantum replacing GPUs,” but hyperscalers or sovereign funds using quantum as a bargaining chip to diversify away from NVDA’s pricing power.

BLK’s role is less about direct return and more about signaling: when a global allocator leans into a frontier theme, it can pull institutional capital behind it and lower financing costs across the cap table. That said, this is still a long-duration trade with high dispersion; the median company remains too early for traditional public-market underwriting, so the exit window can stay episodic and sentiment-driven. NDAQ is a cleaner beneficiary only if the IPO pathway becomes more conventional; otherwise, reverse-merger exits and private secondary transactions blunt the exchange optionality.

The contrarian view is that the current enthusiasm may be front-running a commercialization timeline that slips again, especially if talent and error-correction bottlenecks persist. If investors have already priced quantum as a near-term AI adjacency, the upside is in the plumbing names and strategic holders, not the pure-plays, which are vulnerable to another de-rating once the market realizes revenue inflection is still years away. Geopolitically, the larger risk is not U.S. underinvestment but Europe’s slower regulatory response, which could push capital formation and IP ownership toward U.S.-aligned ecosystems.

Key Decisions for Investors

• Long NVDA vs. a basket of semiconductor peers on a 6-12 month horizon; thesis is that quantum reinforces GPU/AI platform centrality rather than cannibalizing it. Use as a strategic holdings trade, with downside capped if quantum adoption slips because the core AI franchise remains the dominant driver.
• Buy BLK on weakness as a 12-month thematic allocator trade; the benefit is not direct quantum economics but the ability to monetize frontier-asset signaling and win institutional flows. Risk/reward is favorable if the market continues rewarding mega-platform managers that can originate and package strategic alternatives.
• Short a basket of unprofitable quantum pure-plays via any liquid proxy or borrowable names after post-deal spikes; target 3-6 months. The setup is a classic dilution/expectations mismatch: capital intensity is falling on a few leaders, while the median company still lacks a clear commercialization path.
• For NDAQ, consider a call spread only after evidence of a more traditional IPO pipeline in quantum-related names; until then, the cleaner exposure is private markets rather than exchange volumes. This is a conditional catalyst trade, not an immediate buy-the-headline.
• Pair long NVDA / short an equal-risk basket of non-AI frontier hardware names that do not sit at the orchestration layer. If quantum grows as a hybrid compute layer, the capture should accrue to control points, not to the end-user application layer.